Adagrasib inside serious COVID-19: Outcomes of the multicenter, future, one provide, open-label medical study to analyze your usefulness along with safety involving ruxolitinib throughout people with COVID-19 and also significant intense respiratory malady | #adagrasib #fluorouracil #methylhexanamine